Show simple item record

dc.contributorAbu Amero, K.K.EN
dc.date.accessioned2014-06-17T11:18:50Z
dc.date.available2014-06-17T11:18:50Z
dc.date.issued2002EN
dc.identifier.issn1020-3397EN
dc.identifier.otherhttp://applications.emro.who.int/emhj/0804_5/emhj_2002_8_4_5_664_670.pdfEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/119211
dc.description664-670EN
dc.description.abstractAll published material on the prevalence of drug-resistant tuberculosis within Saudi Arabia over the period 1979-98 was reviewed. The prevalence of single-drug-resistant tuberculosis ranged from 3.4% to 41% for isoniazid, 0% to 23.4% for rifampicin, 0.7% to 22.7% for streptomycin and 0% to 6.9% for ethambutol. The prevalence of multidrug-resistant tuberculosis [‎defined by WHO as resist1qance to two or more first-line antituberculosis drugs]‎ ranged from 1.5% to 44% in different regions. No strong conclusions could be drawn owing to variations in the populations studied, geographical origins, site of Mycobacterium tuberculosis isolation [‎pulmonary or extrapulmonary]‎ and drug sensitivity testing. However, the need to develop a standardized national policy for surveillance of drug-resistant tuberculosis in Saudi Arabia is clearEN
dc.language.isoenEN
dc.subjectAntitubercular AgentsEN
dc.subjectDrug Resistance, Multiple, BacterialEN
dc.subjectEpidemiology, MolecularEN
dc.subjectMicrobial Sensitivity TestsEN
dc.subjectPopulation SurveillanceEN
dc.subjectPrevalenceEN
dc.subjectResearch DesignEN
dc.subjectResidence CharacteristicsEN
dc.subject.meshTuberculosis, Multidrug-ResistantEN
dc.titleStatus of antituberculosis drug resistance in Saudi Arabia 1979-98EN
dc.relation.ispartofjournalEMHJ - Eastern Mediterranean Health Journal, 8 (‎4-5)‎, 664-670, 2002


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record